These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21925435)

  • 21. Cardio-Pulmonary-Renal Interactions: A Multidisciplinary Approach.
    Husain-Syed F; McCullough PA; Birk HW; Renker M; Brocca A; Seeger W; Ronco C
    J Am Coll Cardiol; 2015 Jun; 65(22):2433-48. PubMed ID: 26046738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiorenal syndromes: pathogenetic, clinico-diagnostic, prognostic and therapeutic aspects].
    Moiseev VS; Kobalava ZhD
    Ter Arkh; 2011; 83(12):5-11. PubMed ID: 22416437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardio-renal syndrome: new perspective in diagnostics.
    Iyngkaran P; Schneider H; Devarajan P; Anavekar N; Krum H; Ronco C
    Semin Nephrol; 2012 Jan; 32(1):3-17. PubMed ID: 22365157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on cardiorenal Syndrome: a clinical conundrum.
    Chan EJ; Dellsperger KC
    Adv Perit Dial; 2011; 27():82-6. PubMed ID: 22073835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key issues in end point selection for heart failure trials: composite end points.
    Neaton JD; Gray G; Zuckerman BD; Konstam MA
    J Card Fail; 2005 Oct; 11(8):567-75. PubMed ID: 16230258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiorenal syndrome.
    Ronco C; Di Lullo L
    Heart Fail Clin; 2014 Apr; 10(2):251-80. PubMed ID: 24656104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical development of pharmacologic agents for acute heart failure syndromes: a proposal for a mechanistic translational phase.
    Gheorghiade M; Pang PS; O'Connor CM; Prasad K; McMurray J; Teerlink JR; Fiuzat M; Sabbah H; Komajda M
    Am Heart J; 2011 Feb; 161(2):224-32. PubMed ID: 21315202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiorenal syndrome - biomarkers and mediators].
    Charvát J
    Vnitr Lek; 2016; 62(9 Suppl 3):73-76. PubMed ID: 27734695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiorenal syndrome--current understanding and future perspectives.
    Braam B; Joles JA; Danishwar AH; Gaillard CA
    Nat Rev Nephrol; 2014 Jan; 10(1):48-55. PubMed ID: 24247284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel biomarkers and therapies in cardiorenal syndrome.
    Latini R; Aleksova A; Masson S
    Curr Opin Pharmacol; 2016 Apr; 27():56-61. PubMed ID: 26894469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is old is now new: insights into cardiorenal physiology.
    Shah RV; Givertz MM
    J Card Fail; 2014 Dec; 20(12):920-2. PubMed ID: 25270714
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiorenal syndrome type 2--literature review].
    Novosel D; Bašić-Jukić N; Makarović Z; Makarović S
    Acta Med Croatica; 2014 Apr; 68(2):161-5. PubMed ID: 26012154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers in Cardiorenal Syndromes.
    Fu S; Zhao S; Ye P; Luo L
    Biomed Res Int; 2018; 2018():9617363. PubMed ID: 29693019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The pathogenetic bases of cardiorenal syndrome].
    Beloglazova IP; Mogutova PA; Poteshkina NG
    Ter Arkh; 2012; 84(9):97-103. PubMed ID: 23091862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume overload and cardiorenal syndromes.
    Ronco C; Maisel A
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():Si-iv; quiz Svi. PubMed ID: 20653717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality?
    Cohn J; Cleland JG; Lubsen J; Borer JS; Steg PG; Perelman M; Zannad F
    J Card Fail; 2009 Apr; 15(3):199-205. PubMed ID: 19327621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiorenal syndrome in acute decompensated heart failure.
    Sarraf M; Masoumi A; Schrier RW
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):2013-26. PubMed ID: 19965544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute cardiorenal syndrome: recovery of renal function after renal replacement therapy].
    Lubas A; Próchnicka A; Syta U; Niemczyk S
    Kardiol Pol; 2013; 71(1):61-2. PubMed ID: 23348536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.